Regeneron Pharmaceuticals Trading Volume Plummets 43.54% to 180th Position

On May 13, 2025, Regeneron Pharmaceuticals, Inc. (REGN) experienced a significant decline, with its trading volume reaching $611 million, a 43.54% decrease from the previous day. This placed Regeneron at the 180th position in terms of trading volume for the day. The stock price of Regeneron also decreased by 0.26%.

Regeneron Pharmaceuticals, Inc. is scheduled to participate in the BofA Securities 2025 Healthcare Conference on May 13, 2025, at 1:00 PM ET. Ryan Crowe, the Senior Vice President of Investor Relations, will represent the company at the event. This conference provides a platform for Regeneron to engage with investors and industry experts, potentially influencing market sentiment and investor confidence in the company's future prospects.